Generally speaking, you want to minimize your exposure to cheap stocks under $10. Yes, smaller companies have the potential to rise dramatically higher than their larger counterparts. In part, that’s because they’re unpredictable – and this ambiguity cuts both ways. Sure, cheap stocks under $10 have the benefit of the law of small numbers working […]
Wednesday’s trading session provided some serious doubt for investors in Intel (NYSE:INTC) stock after the Pentagon withdrew its $2.5 billion chip grant for the company. The decline brought INTC stock down 3%, and has some investors questioning whether this is a chip stock to buy right now. This decision could reduce federal funding for Intel […]
The biotech sector, in particular, is offering a compelling and timely opportunity. Hello, Reader. A polarizing debate has long plagued the nation, even the world… Which flavor is better, chocolate or vanilla? Hard stances are usually taken. Chocolate lovers never bend, and vanilla enthusiasts remain, well, enthusiastic. I myself am a hard-core vanilla guy. When […]
Finding the next great investment is alluring, almost like a siren’s song. For this, one must possess a crystal ball to identify the stocks about to soar, elevating portfolios to unprecedented heights. Ok, let’s set aside the crystal ball. Let’s dive into three titans in their own fields with stories full of potential and promise. […]
Microsoft (NASDAQ:MSFT) Copilot now offers GPT-4 Turbo for free. I don’t know what that means for MSFT stock, but it shows the company’s commitment to AI. CNET contributor Don Reisinger points out that the move is a sign OpenAI is likely close to launching GPT-4.5 Turbo, which would be for Copilot Pro users who pay […]
I want to talk about why the U.S. is an oasis. In the wake of Super Tuesday, it is now clear that the election will be a rematch between former President Donald Trump and current President Joe Biden. You can bet that temperatures will rise as we approach the election. Meanwhile, there are a lot […]
Source: iQoncept / Shutterstock Calidi Biotherapeutics (NYSEMKT:CLDI) just reported results for the fourth quarter of 2023. Calidi Biotherapeutics reported earnings per share of -23 cents. This was below the analyst estimate for EPS of -20 cents. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from […]
Source: iQoncept / Shutterstock Citizens & Northern (NASDAQ:CZNC) just reported results for the fourth quarter of 2023. Citizens & Northern reported earnings per share of 28 cents. This was below the analyst estimate for EPS of 34 cents. The company reported revenue of $25.27 million. This was 5.28% worse than the analyst estimate for revenue […]
Last week, we were given a reprieve from major economic data; the fourth-quarter earnings season was nearly complete, and there were only a few economic reports on deck. This week, we were treated to three very important economic reports: the Consumer Price Index (CPI) and Producer Price Index (PPI) readings for February and the February […]
Find the best-performing Dividend Aristocrats in industries such as finance, healthcare, materials, and energy In the middle of ongoing market uncertainty, a small subset of businesses is known as the Dividend Aristocrats, which have raised their dividends consistently, at least in the last 25 years. These companies continue to be solid, reliable, and growing. These […]